Evidence map›Paper›PMID 24840981›Full record

ReviewNature immunology2014

Translational control of immune responses: from transcripts to translatomes.

Ciriaco A Piccirillo, Eva Bjur, Ivan Topisirovic, Nahum Sonenberg, Ola Larsson

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 1 synthesis or guideline pooled it, 261 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ribosome Homeostasis Regulated by SETD2 Preserves Intestinal Epithelial Barrier.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Multimodal analysis definesbioRxiv : the preprint server for biology · 2025
    Article
  18. Effects of CRISPR-Cas9-mediatedMolecular therapy. Methods & clinical development · 2025
    Article
  19. Article
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ciriaco A Piccirillo1] Department of Microbiology and Immunology, and Microbiome and Disease Tolerance Centre, McGill University, Montreal, Canada. [2] FOCIS Centre of Excellence and Centre for Translational Biology, Research Institute of the McGill University Health Centre, Montreal, Canada.
Eva BjurDepartment of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
Ivan Topisirovic1] Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montréal, Canada. [2] Department of Oncology, McGill University, Montréal, Canada.
Nahum SonenbergDepartment of Biochemistry, and Goodman Cancer Research Centre, McGill University, Montreal, Canada.
Ola LarssonDepartment of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SEMcGill University · CAMcGill University Health Centre · CA

Funding

Canadian Institutes of Health Research MOP 67211
6 · The paper itself

Abstract

Selective translational control of gene expression is emerging as a principal mechanism for the regulation of protein abundance that determines a variety of functions in both the adaptive immune system and the innate immune system. The translation-initiation factor eIF4E acts as a node for such regulation, but non-eIF4E mechanisms are also prevalent. Studies of 'translatomes' (genome-wide pools of translated mRNA) have facilitated mechanistic discoveries by identifying key regulatory components, including transcription factors, that are under translational control. Here we review the current knowledge on mechanisms that regulate translation and thereby modulate immunological function. We further describe approaches for measuring and analyzing translatomes and how such powerful tools can facilitate future insights on the role of translational control in the immune system.

Indexed as

Transcription, GeneticAdaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsEukaryotic Initiation Factor-4EGene Expression RegulationHumansImmune SystemMechanistic Target of Rapamycin Complex 1MiceMultiprotein ComplexesPhosphoproteinsProtein BiosynthesisRNA, MessengerTOR Serine-Threonine KinasesAdaptor Proteins, Signal TransducingCell Cycle ProteinsEIF4EBP1 protein, humanEukaryotic Initiation Factor-4EMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphoproteinsRNA, MessengerTOR Serine-Threonine Kinases

Identifiers

PMID24840981
OpenAlexW2009776996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.